Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1998, p. 3674-3679, Vol. 36, No. 12
Division of Clinical Microbiology, Department
of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
55905,1 and
Perkin-Elmer Applied
Biosystems Division, Foster City, California 944042
Received 2 June 1998/Returned for modification 23 July
1998/Accepted 3 September 1998
Rapid and accurate identification of bacterial pathogens is a
fundamental goal of clinical microbiology, but one that is difficult or
impossible for many slow-growing and fastidious organisms. We used
identification systems based on cellular fatty acid profiles (Sherlock;
MIDI, Inc., Newark, Del.), carbon source utilization (Microlog; Biolog,
Inc., Hayward, Calif.), and 16S rRNA gene sequence (MicroSeq;
Perkin-Elmer Applied Biosystems Division, Foster City, Calif.) to
evaluate 72 unusual aerobic gram-negative bacilli isolated from
clinical specimens at the Mayo Clinic. Compared to lengthy conventional
methods, Sherlock, Microlog, and MicroSeq were able to identify 56 of
72 (77.8%), 63 of 72 (87.5%), and 70 of 72 (97.2%) isolates to the
genus level (P = 0.002) and 44 to 65 (67.7%), 55 of
65 (84.6%), and 58 of 65 (89.2%) isolates to the species level
(P = 0.005), respectively. Four
Acinetobacter and three Bordetella isolates
which could not be identified to the species level by conventional
methods were identified by MicroSeq. In comparison to the full 16S rDNA
sequences, the first 527 bp provided identical genus information for
all 72 isolates and identical species information for 67 (93.1%)
isolates. These data show that MicroSeq provides rapid, unambiguous
identification of clinical bacterial isolates. The improved turnaround
time provided by genotypic identification systems may translate into
improved clinical outcomes.
Accurate identification of bacterial
isolates is an essential task of the clinical microbiology laboratory.
For many slow-growing and fastidious organisms, traditional phenotypic
identification is difficult and time-consuming. In addition, when
phenotypic methods are used to identify bacteria, interpretation of
test results involves substantial subjective judgement (34).
Several commercial systems offer computer-assisted identification of a wide variety of bacterial organisms. Such systems include the carbon
source utilization system developed by Biolog, Inc., based on panels of
biochemical reactions (18, 24), and the gas-liquid chromatography system developed by MIDI, Inc. (Newark, Del.), based on
the cellular fatty acid profile (27, 37). Such systems may
reduce subjectivity and turnaround time, but they still rely on
phenotypic identification.
Genotypic identification is emerging as an alternative or complement to
established phenotypic methods. Typically, genotypic identification of
bacteria involves the use of conserved sequences within
phylogenetically informative genetic targets, such as the small-subunit
(16S) rRNA gene (20, 23, 30, 41, 43). Broad-range PCR
primers recognize conserved sequences in a variety of bacteria, while
amplifying highly variable regions between the primer binding sites
(3, 6, 14, 31, 39, 41). The amplified segment is sequenced
and compared with known databases to identify a close relative (8,
20, 22, 25, 29, 30).
The MicroSeq 16S rRNA gene kit (Perkin-Elmer Applied Biosystems
Division [PE-ABD], Foster City, Calif.) allows identification of
bacteria based on the sequences of their 16S rRNA gene (21, 32). Genomic DNA extracted from bacteria is amplified and then sequenced. Sequence analysis software compares genes analyzed from
unknown bacteria to a proprietary 16S rDNA sequence library. Although
the MicroSeq system was developed specifically for the identification
of environmental microorganisms, we have been interested in the use of
this system for identifying clinical isolates, some of which may be
synonymous with environmental isolates.
We report a comparative evaluation of three bacterial identification
systems which are based on cellular fatty acid profiles (Sherlock),
biochemical reactions (Microlog), and 16S rRNA gene sequence analysis
(MicroSeq). These three methods were tested for their ability to
differentiate 72 clinical isolates of unusual aerobic gram-negative
bacilli. All these commercial systems were also compared with
conventional phenotypic evaluation standards.
(This study was presented in part at the 98th General Meeting of the
American Society for Microbiology, Atlanta, Ga., 17 to 21 May 1998.)
Clinical isolates.
With the exception of two isolates, the
gram-negative bacilli evaluated for this study were clinical
consecutive isolates received by the Mayo Referral Bacteriology
Laboratory during February and March 1997. Each isolate was screened by
the computer-assisted replica plating (CARP) system developed at the
Mayo Clinic (36, 38). CARP identifies gram-negative bacilli
based on citrate, lysine and ornithine decarboxylase, urease, DNase,
colistin, cephalosporinase, hydrogen sulfide, esculin hydrolysis, and
arginine dihydrolase and on the fermentation of D-glucose,
lactose, D-mannitol, sucrose, inositol, and
L-arabinose. Isolates unidentifiable by CARP (approximately 10 to 15% of all isolates) were considered unusual and evaluated in
our study.
Conventional methods Cellular fatty acid profile.
After 24 to 48 h growth at
28°C on Trypticase soy broth agar plates or at 35°C on 5% sheep
blood agar plates, bacteria were saponified, and the liberated fatty
acids were methylated and analyzed by capillary gas-liquid
chromatography (1, 9) by the Sherlock system with the
trypticase soy broth agar or CLIN aerobe database 3.9 (MIDI, Inc.)
precisely according to the manufacturer's instructions. The results
for each isolate were computed as a similarity index. Similarity
indices from 0.5 to 0.9 were considered reliable for identifying
individual species (27, 37).
Biolog microstation system.
Single colonies were chosen,
subcultured on 5% sheep blood agar plates, and incubated overnight at
35°C. A homogenous suspension of inoculum was made in 0.85% saline
and diluted to a transmittance of 55 to 60% at 590 nm. One hundred
fifty microliters of the suspension was dispensed into each well of the
GN Microlog microplate, which was incubated for 24 h at 35°C.
Microplates were read at 590 nm at 4 and 24 h with a
computer-controlled MicroPlate reader (18, 24). Each
metabolic profile was compared automatically with the GN Microlog
database (release 3.50).
Sequence analysis of 16S rRNA gene.
The MicroSeq system
contains a PCR and cycle sequencing module, bacterial identification
and analysis software, and a 16S rDNA sequence database library (Fig.
1). For DNA preparation (step A, Fig. 1),
a loopful of bacterial cells was washed with distilled water and
incubated with 200 µl of 5% Chelex solution (PE-ABD) for 15 min at
56°C. The suspension was vortexed and heated for 8 min at 100°C and
centrifuged at 8,000 × g for 2 min. Two microliters of
a 10-fold dilution of the supernatant was used for PCR amplification.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Comparison of Phenotypic and Genotypic Techniques
for Identification of Unusual Aerobic Pathogenic Gram-Negative
Bacilli

![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
evaluation standard.
Unusual
gram-negative bacilli were tested with one of two biochemical panels,
one for glucose fermenters and one for nonfermenters. Classification
was based on criteria used in the Enteric Bacteriology Laboratory and
the Special Bacteriology Laboratory at the Centers for Disease Control
and Prevention, Atlanta, Ga. (11, 26, 35, 36, 40). Taxonomy
was based on newly published nomenclature (5).

View larger version (29K):
[in a new window]
FIG. 1.
Flowchart of the MicroSeq process from culture to
sequence. The total elapsed time was 15.5 to 18.5 h, comprising
bacterial DNA extraction (A), PCR (B), sequencing reaction preparation
(C), cycle sequencing (D), and analysis (E). The time required for each
step is indicated.
Statistics. Comparisons of agreement rate with results of conventional methods (based on rate ratios) were performed with Epiinfo, version 6, Centers for Disease Control and Prevention.
| |
RESULTS |
|---|
|
|
|---|
All 72 isolates in our study were identified to genus level, and 65 isolates were identified to species level by conventional Mayo methods, which served as our evaluation standard. The isolates identified to the species level included 25 fermenters (1 Citrobacter braakii species, 1 Citrobacter farmeri species, 2 Citrobacter koseri species, 2 Enterobacter aerogenes species, 1 Enterobacter agglomerans species, 6 Enterobacter cloacae species, 3 E. coli species, 1 Klebsiella pneumoniae species, 1 Klebsiella oxytoca species, 1 Kluyvera cryocrescens species, 1 Leclercia adecarboxylata species, 2 Pasteurella multocida species, 1 Providencia rettgeri species, 1 Providencia stuartii species, and 1 Serratia odorifera species) and 40 nonfermenters (2 Acinetobacter lwoffii species, 1 Alcaligenes faecalis species, 3 Alcaligenes xylosoxidans species, 1 Brevundimonas dimunuta species, 1 Brevundimonas vesicularis species, 3 Burkholderia cepacia species, 1 Moraxella osloensis species, 2 Oligella urethralis species, 7 Pseudomonas aeruginosa species, 6 Pseudomonas fluorescens species or Pseudomonas putida species, 1 Pseudomonas pictorum species, 1 Pseudomonas stutzeri species, and 11 Stenotrophomonas maltophilia species).
Seven isolates could not be identified to the species level by phenotypic identification systems including Sherlock, Microlog, and the conventional Mayo methods (Table 1). These were all identified at species level by the MicroSeq system. These organisms were identified as two Acinetobacter baumannii species, one Acinetobacter calcoaceticus species, one Acinetobacter junii species, and three Bordetella holmesii species (35).
|
Among the three identification systems evaluated, genotypic
identification by MicroSeq had the highest concordance with
conventional methods (Table 1). At the genus level, agreement with
conventional methods was 97.2% for MicroSeq compared to 87.5% for
Microlog (
2 = 4.82, P = 0.028) and
77.8% for Sherlock (
2 = 12.44, P < 0.001).
MicroSeq demonstrated better performance with nonfermentative bacilli
than with fermenters (principally Enterobacteriaceae).
We tested the efficacy of identification based on subregion analysis in comparison to the full 16S rDNA sequence. Table 2 showed that region A, which covered first 527 bp, gave the same genus information for all 72 isolates as the full 16S rRNA gene. Region A provided same species identification as full sequence data for 46 (97.9%) of 47 nonfermenters and 21 (84.0%) of 25 fermenters.
|
The identification of seven isolates by the MicroSeq system differed from that provided by the conventional Mayo method, according to which six of these isolates were identified as E. cloacae species. We analyzed the 16S rDNA sequence derived from these 6 isolates, 11 Enterobacteriaceae stored in the MicroSeq database, and 8 Enterobacter species available in GenBank (15, 16). The six mismatched isolates fell into three clusters. Genotypically related isolates within a defined cluster had different biochemical profiles, including those generated by both the conventional Mayo method and the Microlog methods (data not shown). The sequences of these six E. cloacae isolates had a difference rate of 0.98 to 2.42% (mean ± standard deviation, 1.90% ± 0.47%) from the reference E. cloacae strain. The difference rate was 1.39 to 1.62% (mean ± standard deviation, 1.52% ± 0.10%) among three clusters and <0.5% within the clusters (Fig. 2).
|
| |
DISCUSSION |
|---|
|
|
|---|
Clinical and public health interventions depend on rapid, accurate identification of pathogenic bacteria. We have shown that genotypic methods based on 16S rDNA sequence analysis improved the identification of aerobic gram-negative pathogens compared to conventional phenotypic methods, cellular fatty acid profiles, and a carbon source utilization system. Four Acinetobacter and three Bordetella isolates which could not be identified to the species level by conventional methods were identified by the MicroSeq system by using phylogenetic analysis.
For decades, microbiologists have sought improved pathogen identification through the use of phenotypic methods. Abel and colleagues first suggested that microorganisms could be classified by gas chromatographic analysis (1). These concepts found application in the form of the Sherlock system. The Sherlock system bases organism identification solely on computer comparison of the unknown organism's fatty acid methyl ester profile with the profiles of a predetermined library of known isolates with pattern recognition software. Osterhout and associates found that the system correctly identified 478 of 532 (89.8%) clinical isolates and reference strains of gram-negative nonfermentative bacteria. The majority of the strains for which gas-liquid chromatography identification did not agree with biochemical criteria belonged to the genera Acinetobacter, Moraxella, Alcaligenes, and Pseudomonas, all of which were among our isolates (27). In our study, Sherlock identified only 67.7% of isolates to the species level, presumably because the easily identified species had already been screened out by CARP (see Materials and Methods).
Traditional phenotypic identification relies upon biochemical pathways and carbon source utilization. Investigators over the years have tried a variety of improvements through automation. One such effort is the Microlog system, comprising a microtiter plate that tests for the ability of a microorganism to utilize different carbon sources. The test yields a pattern of colored wells that constitutes a metabolic fingerprint of the inoculated organism. Preliminary evaluation revealed that the system performed well with many genera, but problems were encountered with some strains of Klebsiella, Enterobacter, and Serratia (24). Holmes and colleagues have evaluated the system with 214 strains of nonfermenters representing 15 species (18). The authors noted that no other commercial identification system has as many organisms in a single database as that supplied by Microlog, but even the large number of tests available may not be adequate for discriminating all clinically relevant pairs of taxa (18). The Microlog system possesses the limitations of all biochemical identification schemes, since (i) individual tests may not be highly reproducible and (ii) the species metabolic phenotype is not an absolute property but may exhibit variability.
We found that 16S rRNA gene sequences frequently provide phylogenetically useful information. Signature nucleotides allow classification even if a particular sequence has no match in the database, since otherwise-unrecognizable isolates can be assigned to a phylogenetic branch at the class, family, genus, or subgenus level. We also note that identification of slow-growing or biochemically inert gram-negative bacilli to the species level is difficult and time-consuming by conventional methods (13, 17, 19, 35). In the present study, seven species (four Acinetobacter spp. and three Bordetella spp.) that could not be identified by exhaustive phenotypic methods were all assigned a definite species identification by the MicroSeq system. Direct sequence determination of 16S rRNA gene fragments represents a highly accurate and versatile method for identification of bacteria to the species level, even when the species in question is notoriously difficult to identify by biochemical means.
Some of the potential difficulties of the interpretation 16S sequence analysis were also noted in this study. Reliable genotypic identification requires accurate and complete genetic databases. In our study, six isolates identified as E. cloacae species by the conventional Mayo methods were assigned to other taxa by the MicroSeq system. Phylogenetic analysis indicated that these six isolates fell into three clusters, with a 1.52% difference rate among them (Fig. 2). Since a difference rate of >0.5% is generally considered a new species within a given genus (28, 33), the 16S sequence divergence among these strains suggests that they may in fact be new species. E. cloacae is one of the most-difficult Enterobacteriaceae to identify due to its variable biochemical and antibiogram profiles (2, 7, 42). We conclude from the evaluation of these isolates that more E. cloacae strains need to be included in genetic databases and that subdivision of E. cloacae into several new species may be indicated.
Another potential limitation of the 16S rDNA sequencing application in general is the inability to assign a species for recently diverged species (10, 12, 44). Since our study was limited to gram-negative bacilli and to a relatively small number of analyses, we did not encounter this problem. However, if this problem does become significant, 16S sequence analysis could be envisioned as a screening platform on which to assign additional analytical procedures such as sequencing protein coding genes or the intergenic spacer region of the ribosomal gene complex for increased variability.
The speed of microbial identification results can have a major impact
on clinical management. Identification of bacteria by conventional
methods usually requires
48 h after a discrete colony has been
isolated. Two weeks are required for the identification of many
slow-growing and fastidious organisms by conventional methods. In some
circumstances, no identification can be made after weeks of analysis,
even by an experienced technologist. Although commercially available
identification systems such as Biolog and Sherlock sometimes shorten
turnaround time, these systems often require prolonged growth before a
fastidious organism can be assayed and a percentage of unusual
organisms is always unidentifiable. In contrast, the MicroSeq system
can be completed within 48 h with a minimal amount of starting material.
Cost is a critical issue in the evaluation of 16S rDNA sequence analysis as a diagnostic tool. Driven in part by the technology underlying the human and microbial genome projects, sequencing costs will probably continue their rapid trend downward, bringing this technology within the reach of many microbiology laboratories (32). Our results indicate that the first 527 bp gave the same genus identification as full sequence data from all 72 clinical isolates evaluated. Sequence analysis of this region needs only one amplification step and two sequence reactions; therefore, the price of reagents approaches the costs of the reagents and labor for many phenotypic methods. Since genus-level information is usually sufficient for clinical diagnostic purposes, sequence analysis of the first 527 bp of the 16S rRNA gene may be the first-tier test to be considered in laboratories with automated sequencing equipment. A MicroSeq 500 16S bacterial sequencing kit designed to sequence the first 527 bp of the 16S rRNA gene is currently being developed.
| |
ACKNOWLEDGMENTS |
|---|
We thank Scott Anderson, Michael Waddington, John Bartell, Maggie Riehman, Patrick Collins, Dan Chapman, Stacy Montogomery, Kelly Doerr, Sherri Wohlfiel, Jean Gutschenritter, Robert Segner, Janice Gillard, Patricia Schams, Jeanne Licari, Dianne McGrath, Sandra Borsheim, Carol McKibbon, Shirley Pokorski, and Jonathan Hibbs for their assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Laboratory Medicine and Pathology, Hilton 470, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905. Phone: (507) 284-2876. Fax: (507) 284-4272. E-mail: persing.david{at}mayo.edu.
Present address: Departments of Medicine and Pathology, Vanderbilt
University Medical Center, A3310 MCN, Nashville, TN 37232-2605.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abel, K.,
H. de Schmertzing, and J. I. Peterson.
1963.
Classification of microorganisms by analysis of chemical composition. I. Feasibility of utilizing gas chromatography.
J. Bacteriol.
85:1039-1044 |
| 2. | Andersen, B. M. 1995. Biochemical profiles and serotypes of nosocomial Enterobacter cloacae strains in Northern Norway: biochemical identification problems with commercial test systems. Infection 23:339-343[Medline]. |
| 3. | Bottger, E. C., A. Teske, P. Kirschner, S. Bost, H. R. Chang, V. Beer, and B. Hirschel. 1992. Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet 340:76-80[Medline]. |
| 4. |
Brosius, J.,
M. L. Palmer,
P. J. Kennedy, and H. F. Noller.
1978.
Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli.
Proc. Natl. Acad. Sci. USA
75:4801-4805 |
| 5. | Bruckner, D. A., and P. Colonna. 1997. Nomenclature for aerobic and facultative bacteria. Clin. Infect. Dis. 25:1-10[Medline]. |
| 6. | Chen, K., H. Neimark, P. Rumore, and C. R. Steinman. 1989. Broad range DNA probes for detecting and amplifying eubacterial nucleic acids. FEMS Microbiol. Lett. 48:19-24[Medline]. |
| 7. | Doern, G. V., A. B. Brueggemann, R. Perla, J. Daly, D. Halkias, R. N. Jones, and M. A. Saubolle. 1997. Multicenter laboratory evaluation of the bioMerieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa. J. Clin. Microbiol. 35:2115-2119[Abstract]. |
| 8. |
Eden, P. A.,
T. M. Schmidt,
R. P. Blakemore, and N. R. Pace.
1991.
Phylogenetic analysis of Aquaspirillum magnetotacticum using polymerase chain reaction-amplified 16S rRNA-specific DNA.
Int. J. Syst. Bacteriol.
41:324-325 |
| 9. |
Eerola, E., and O. P. Lehtonen.
1988.
Optimal data processing procedure for automatic bacterial identification by gas-liquid chromatography of cellular fatty acids.
J. Clin. Microbiol.
26:1745-1753 |
| 10. |
Enright, M. C.,
P. E. Carter,
I. A. MacLean, and H. McKenzie.
1994.
Phylogenetic relationships between some members of the genera Neisseria, Acinetobacter, Moraxella, and Kingella based on partial 16S ribosomal DNA sequence analysis.
Int. J. Syst. Bacteriol.
44:387-391 |
| 11. |
Farmer, J. J., III,
B. R. Davis,
F. W. Hickman-Brenner,
A. McWhorter,
G. P. Huntley-Carter,
M. A. Asbury,
C. Riddle,
H. G. Wathen-Grady,
C. Elias,
G. R. Fanning, et al.
1985.
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.
J. Clin. Microbiol.
21:46-76 |
| 12. |
Fox, G. E.,
J. D. Wisotzkey, and P. Jurtshuk, Jr.
1992.
How close is close: 16S rRNA sequence identity may not be sufficient to guarantee species identity.
Int. J. Syst. Bacteriol.
42:166-170 |
| 13. |
Gerner-Smidt, P.,
I. Tjernberg, and J. Ursing.
1991.
Reliability of phenotypic tests for identification of Acinetobacter species.
J. Clin. Microbiol.
29:277-282 |
| 14. |
Greisen, K.,
M. Loeffelholz,
A. Purohit, and D. Leong.
1994.
PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.
J. Clin. Microbiol.
32:335-351 |
| 15. | Harada, H., J. Oyaizu, and H. Ishikawa. 1996. A consideration about the origin of aphid intracellular symbiont in connection with gut bacterial flora. J. Gen. Appl. Microbiol. 42:17-26. |
| 16. | Hauben, L., E. R. Moore, L. Vauterin, J. Mergaert, L. Verdonck, and J. Sings. Phylogenetic analysis of phytopathogens within the Enterobacteriaceae. Submitted for publication. |
| 17. |
Hollis, D. G.,
C. W. Moss,
M. I. Daneshvar,
L. Meadows,
J. Jordan, and B. Hill.
1993.
Characterization of Centers for Disease Control group NO-1, a fastidious, nonoxidative, gram-negative organism associated with dog and cat bites.
J. Clin. Microbiol.
31:746-748 |
| 18. |
Holmes, B.,
M. Costas,
M. Ganner,
S. L. On, and M. Stevens.
1994.
Evaluation of Biolog system for identification of some gram-negative bacteria of clinical importance.
J. Clin. Microbiol.
32:1970-1975 |
| 19. | Kampfer, P., I. Tjernberg, and J. Ursing. 1993. Numerical classification and identification of Acinetobacter genomic species. J. Appl. Bacteriol. 75:259-268[Medline]. |
| 20. |
Kirschner, P.,
B. Springer,
U. Vogel,
A. Meier,
A. Wrede,
M. Kiekenbeck,
F. C. Bange, and E. C. Bottger.
1993.
Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory.
J. Clin. Microbiol.
31:2882-2889 |
| 21. | Lambert, L. H., T. Cox, K. Mitchel, R. A. Rossello-Mora, C. Del Cueto, D. E. Dodge, P. Orkand, and R. J. Cano. Staphylococcus succinus, sp. nov., isolated from Dominican Amber. Submitted for publication. |
| 22. |
Lane, D. J.,
B. Pace,
G. J. Olsen,
D. A. Stahl,
M. L. Sogin, and N. R. Pace.
1985.
Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses.
Proc. Natl. Acad. Sci. USA
82:6955-6959 |
| 23. |
Maurin, M.,
V. Roux,
A. Stein,
F. Ferrier,
R. Viraben, and D. Raoult.
1994.
Isolation and characterization by immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blot, restriction fragment length polymorphism-PCR, 16S rRNA gene sequencing, and pulsed-field gel electrophoresis of Rochalimaea quintana from a patient with bacillary angiomatosis.
J. Clin. Microbiol.
32:1166-1171 |
| 24. |
Miller, J. M., and D. L. Rhoden.
1991.
Preliminary evaluation of Biolog, a carbon source utilization method for bacterial identification.
J. Clin. Microbiol.
29:1143-1147 |
| 25. | Monstein, H. J., E. Kihlstrom, and A. Tiveljung. 1996. Detection and identification of bacteria using in-house broad range 16S rDNA PCR amplification and genus-specific DNA hybridization probes, located within variable regions of 16S rRNA genes. APMIS 104:451-458[Medline]. |
| 26. | Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken. 1995. Manual of clinical microbiology, 6th ed. American Society for Microbiology Press, Washington, D.C. |
| 27. |
Osterhout, G. J.,
V. H. Shull, and J. D. Dick.
1991.
Identification of clinical isolates of gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system.
J. Clin. Microbiol.
29:1822-1830 |
| 28. |
Palys, T.,
L. K. Nakamura, and F. M. Cohan.
1997.
Discovery and classification of ecological diversity in the bacterial world: the role of DNA sequence data.
Int. J. Syst. Bacteriol.
47:1145-1156 |
| 29. |
Persing, D. H.,
B. L. Herwaldt,
C. Glaser,
R. S. Lane,
J. W. Thomford,
D. Mathiesen,
P. J. Krause,
D. F. Phillip, and P. A. Conrad.
1995.
Infection with a babesia-like organism in northern California.
N. Engl. J. Med.
332:298-303 |
| 30. | Relman, D. A., J. S. Loutit, T. M. Schmidt, S. Falkow, and L. S. Tompkins. 1990. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N. Engl. J. Med. 323:1573-1580[Abstract]. |
| 31. |
Schriefer, M. E.,
J. B. Sacci, Jr.,
J. S. Dumler,
M. G. Bullen, and A. F. Azad.
1994.
Identification of a novel rickettsial infection in a patient diagnosed with murine typhus.
J. Clin. Microbiol.
32:949-954 |
| 32. | Smith, D. H., and D. E. Dodge. 1997. Rapid, sequence-based microbial identification. Conference on Molecular Diagnostics and Therapeutics. American Society for Microbiology, Kananaskis, Alberta, Canada. |
| 33. |
Stackebrandt, E., and B. M. Goebel.
1994.
Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology.
Int. J. Syst. Bacteriol.
44:846-849 |
| 34. |
Stager, C. E., and J. R. Davis.
1992.
Automated systems for identification of microorganisms.
Clin. Microbiol. Rev.
5:302-327 |
| 35. | Tang, Y. W., M. K. Hopkins, C. P. Kolbert, P. A. Hartley, P. J. Severance, and D. H. Persing. 1998. Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin. Infect. Dis. 26:389-392[Medline]. |
| 36. | Temesgen, Z., D. R. Toal, and F. R. Cockerill, III. 1997. Leclercia adecarboxylata infections: case report and review. Clin. Infect. Dis. 25:79-81[Medline]. |
| 37. | Von Graevenitz, A., G. Osterhout, and J. Dick. 1991. Grouping of some clinically relevant gram-positive rods by automated fatty acid analysis. Diagnostic implications. APMIS 99:147-154[Medline]. |
| 38. | Washington, J. A. 1985. Laboratory procedures in clinical microbiology, 2nd ed. Springer-Verlag, New York, N.Y. |
| 39. |
Weisburg, W. G.,
S. M. Barns,
D. A. Pelletier, and D. J. Lane.
1991.
16S ribosomal DNA amplification for phylogenetic study.
J. Bacteriol.
173:697-703 |
| 40. | Weyant, R. S., C. W. Moss, R. E. Weaver, D. G. Hollis, J. G. Jordan, E. C. Cook, and M. I. Daneshvar. 1996. Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria, 2nd ed. Centers for Disease Control, Atlanta, Ga. |
| 41. |
Wilson, K. H.,
R. B. Blitchington, and R. C. Greene.
1990.
Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction.
J. Clin. Microbiol.
28:1942-1946 |
| 42. |
Winstanley, T. G.,
D. I. Limb,
P. F. Wheat, and C. D. Nicol.
1993.
Multipoint identification of Enterobacteriaceae: report of the British Society for Microbial Technology collaborative study.
J. Clin. Pathol.
46:637-641 |
| 43. |
Woese, C. R.,
O. Kandler, and M. L. Wheelis.
1990.
Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya.
Proc. Natl. Acad. Sci. USA
87:4576-4579 |
| 44. |
Wolff, K.,
S. Sperka, and A. Stern.
1992.
Phylogeny and nucleotide sequence of a 23S rRNA gene from Neisseria gonorrhoeae and Neisseria meningitidis.
Nucleic Acids Res.
20:4657 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|